D-0698-2026 Class II Ongoing
FDA drug recall D-0698-2026 was initiated by Blaine Labs Inc on Apr 8, 2026 and is designated Class II. Reason for recall: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry The recall status is ongoing. Affected quantity: 1,500 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 8, 2026
- Initiation Date
- Apr 8, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,500 bottles
Product description
Fungal Fusion ERADICATION Solution, Antifungal & Antimicrobial Kit. Contains, 1x2 oz bottle Fungal Fusion Antifungal (Miconazole Nitrate) Cream, 1x2oz bottle Fungal Fusion Antifungal Solution (25% Undecylenic Acid) and 1x1oz bottle of Fungal Fusion Eradication Antimicrobial Show Spray (isopropyl Alcohol, D-Limonene, Undecylenic Acid). Manufactured By: Blaine Labs, Inc., 11037 Lockport Place, Santa Fe Springs, CA 90670, Manufactured for Doctor's Inc
Reason for recall
CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry
Distribution pattern
Nationwide in the USA
Code information
Lot BL3572, Exp 04/16/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0698-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026